CRMD:CorMedix Inc Snapshot | Charting | News | Options
$5.42   0.00%  $0.00 NASDAQ 8:30a ET
April 15 '24 		CorMedix Inc. Announces U.S. Inpatient Commercial Availability of DefenCath(R) (Taurolidine and Heparin) GlobeNewswire
Last  Change Exchange
Market data is delayed by at least 15 minutes.
Markets Portfolio
    Symbol Lookup
    Latest Story
    CorMedix Inc. Announces U.S. Inpatient Commercial Availability of DefenCath(R) (Taurolidine and Heparin)
     GlobeNewswire
    Full Story →

    Headline News
    CorMedix Inc. Announces Abstracts at Upcoming Society for Healthcare Epidemiology of America Conference
    8:30a ET April 11 '24 GlobeNewswire
    CorMedix Inc. Announces Commercial Agreement With ARC Dialysis, LLC
    8:30a ET April 8 '24 GlobeNewswire
    CorMedix Inc. to Present at the Needham Annual Healthcare Conference
    8:30a ET March 27 '24 GlobeNewswire
    More News →
    Day  0.00%Week  7.19%Month  42.6%More Charting →
    April 18 '24. Markets Closed.
    Last $5.42
    Day change   0.00%$0.00
    Open $NA
    Gap at open $NA
    Previous close $5.42
    Trading volume NA
    10 Day avg vol. 1,212,835
    Shares out. 55.0Mil
    Market cap. $298.0Mil
    Trading activity Below Avg.
    Previous data from yesterday, April 18 '24.

    Historical Price Performance
    3 month   66.26% 
    6 month   71.52% 
    1 year   14.83% 
    2 year   18.08% 

    Earnings
    Previous 12m -$0.92
    Next 12m Estimate -$0.74
    P/E ratio 5.9x
    Revenue 0Mil

    Market data provided by News provided by


    This site is published in the United States for U.S. residents only. The services offered within this site are available exclusively through our U.S. Financial Advisors. Stifel Nicolaus Financial Advisors may only conduct business with residents of the state in which they are properly registered. The information on this website is not an offer to sell or a solicitation of an offer to buy, any security, nor shall any such security be offered or sold to any person in any jurisdiction in which such offer, solicitation, purchase or sale may not lawfully be made.
    Important Disclosures | Privacy Notice | HIPAA Policy | Use of Information Policy | Business Continuity | Canada Trade Matching Statement

    Stifel, Nicolaus & Co., Inc. Member NYSE, FINRA, and SIPC.
    Stifel Nicolaus Canada Inc., is a member of CIPF/FCPE and IIROC
    Copyright © 2024 All rights reserved.